Patents Examined by Gina C Justice
  • Patent number: 11896588
    Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, Wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
    Type: Grant
    Filed: November 16, 2022
    Date of Patent: February 13, 2024
    Assignee: SYDNEXIS, INC.
    Inventors: Gregory I. Ostrow, Kenneth J. Widder, David S. Baker
  • Patent number: 11890145
    Abstract: An adhesion-preventing material having a high adhesion-preventing effect has been demanded. An adhesion-preventing material including a sterilized biocompatible sponge-like laminate, wherein the sponge-like laminate comprises a sponge-like first layer and a sponge-like second layer each of which is at least partially crosslinked with a curing agent and comprises a low-endotoxin alginic acid monovalent metal salt, the alginic acid monovalent metal salt in the first layer has a weight average molecular weight of 10,000 to 2,000,000, the alginic acid monovalent metal salt in the second layer has a weight average molecular weight of 1,000 to 1,000,000, the weight average molecular weights are measured by a GPC-MALS method after a decrosslinking treatment, and the weight average molecular weight of the alginic acid monovalent metal salt in the first layer is higher than that in the second layer.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: February 6, 2024
    Assignees: The University of Tokyo, Mochida Pharmaceutical Co., Ltd.
    Inventors: Taichi Ito, Seiichi Ohta, Norihiro Kokudo, Mitsuko Isaji, Satoshi Shimizu
  • Patent number: 11890277
    Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
    Type: Grant
    Filed: November 16, 2022
    Date of Patent: February 6, 2024
    Assignee: SYDNEXIS, INC.
    Inventors: Gregory I. Ostrow, Kenneth J. Widder, David S. Baker
  • Patent number: 11883390
    Abstract: Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
    Type: Grant
    Filed: November 16, 2022
    Date of Patent: January 30, 2024
    Assignee: SYDNEXIS, INC.
    Inventors: Gregory I. Ostrow, Kenneth J. Widder, David S. Baker
  • Patent number: 11882837
    Abstract: Provided is a novel bacterial strain Bacteroides vulgatus MGM001 (Bacteroides vulgatus MGM001) and its use. The LPS from the strain of the subject matter has cytotoxicity weaker than the conventional ones and shows synergistic effect on the inhibition of biofilm formation when used in combination with LTA.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: January 30, 2024
    Assignees: SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION, KOREA FOOD & DRUG ADMINISTRATION
    Inventors: Kyu-Ho Lee, Hyo-Sun Kwak, Youchul Jung, Kyung Jo Lee, Jeong-A Kim, Boram Jang, Sebin Kang
  • Patent number: 11872299
    Abstract: The present invention relates to a shear-thinning or pseudoplastic cosmetic composition. Zeta potentials may be balanced such that a first ratio of the first zeta potential to the second zeta potential may be approximately 1:2. A second ratio of the first zeta potential to the third zeta potential may be approximately 1:2. And, a third ratio of the second zeta potential to the third zeta potential may be approximately 1:1. Balancing zeta potentials may ensure the shear-thinning cosmetic composition can dispense in its original viscous form and as a fine mist through a single device.
    Type: Grant
    Filed: August 17, 2022
    Date of Patent: January 16, 2024
    Assignee: ELC MANAGEMENT LLC
    Inventor: Wilson A. Lee
  • Patent number: 11826454
    Abstract: The present invention relates to a cosmetics composition having high anti-oxidant content. Specifically, the anti-oxidant of the present invention may be pure vitamin-C. More specifically, the present invention can maintain the potency of vitamin-C by preventing exposure of same to the outside air.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: November 28, 2023
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Yoonkyun Hwang, Jihye An, Youngsun Kim, Dalsu Na, Byungfhy Suh, Seonga Cho, Byungguen Chae, Dongwon Choi, Sanghoon Han
  • Patent number: 11826458
    Abstract: A method of preparing a ginger water composition containing a ginger extract according to one embodiment of the present invention includes obtaining a ginger extract from a ginger root; mixing an organic solvent with the ginger extract; providing ultrasonic waves and obtaining a first solution; mixing water with the first solution; supplying heat and obtaining a second solution; and filtering the second solution.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: November 28, 2023
    Assignee: HANAMOA CO., LTD.
    Inventors: Yoon Jeong Choi, Eil Sup Yoon
  • Patent number: 11819564
    Abstract: The present invention relates to a composition, preferably a cosmetic composition, and more preferably a skin cosmetic composition, comprising: (a) at least one particle, comprising at least one cationic polymer and at least one anionic polymer, at least one cationic polymer and at least one amphoteric polymer, at least one anionic polymer and at least one amphoteric polymer, or at least one amphoteric polymer, and at least one non-polymeric acid having two or more pKa values or salt(s) thereof or at least one non-polymeric base having two or more pKb values or salt(s) thereof; (b) at least one oil; and (c) water. The composition according to the present invention is stable, and can have a variety of cosmetic functions. For example, the composition according to the present invention can prepare a film which can have cosmetic effects such as moisturizing due to the oil(s).
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: November 21, 2023
    Assignee: L'Oreal
    Inventors: Toshifumi Shiroya, Hidehiko Asanuma, Takehiko Kasai
  • Patent number: 11820900
    Abstract: The present invention relates to interference pigments based on platelet-shaped substrates which are coated with at least four high refractive layers and to the use thereof, inter alia in paints, coatings, printings inks, plastics and in particular in cosmetic formulations. The interference pigments show a moderate chroma and can be used as effect pigments, as filler pigments and as protection agent against near infrared radiation, VIS and high energy light.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: November 21, 2023
    Assignee: Merck Patent GmbH
    Inventors: Michael Termer, Jutta Zur Lage, Anett Moschner, Lilia Heider
  • Patent number: 11806415
    Abstract: An antimicrobial eyelid cleanser composition contains: (a) a hypohalous acid; (b) one or more surfactants having a HLB value of 5 to 18; and (c) an aqueous vehicle, the aqueous vehicle comprising: (i) one or more tonicity adjusters; (ii) one or more osmolality adjusters for adjusting an osmolality of the composition; and (iii) one or more pH adjusters for maintaining the pH of the composition at between about 4.5 to about 8.0. The composition can be dispensed in a foam, liquid, spray, mist, gel or lotion form. The composition can facilitate long term eyelid hygiene by removing excess oil, debris and desquamated skin and provide relief for inflammation of the eyes.
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: November 7, 2023
    Assignee: OCuSOFT, Inc.
    Inventors: Nat Adkins, Jr., Cynthia Barratt, Thomas Mason, Paramita Sarkar
  • Patent number: 11793741
    Abstract: The present invention relates to a topical composition comprising from 0.001 to 10% by weight a compound of formula (I), i.e. N-cyclopropyl nicotinamide, that provides improved antimicrobial effect through generation of antimicrobial peptides when applied to an external surface of the human body. A combination of compound of formula I and at least one ingredient selected from niacinamide, picolinamide and iso-nicotinamide triggers generation of AMPs in a synergistic way.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: October 24, 2023
    Assignee: CONOPCO, INC.
    Inventors: Khushbu Agarwal, Balu Kunjupillai, Amitabha Majumdar
  • Patent number: 11793793
    Abstract: Methods of reducing hepatitis delta virus (HDV) viral loads in a patient are provided. In some embodiments, the method comprises treating the patient with lonafarnib-ritonavir co-therapy. In some embodiments, the method further comprises treating the patient with an interferon.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: October 24, 2023
    Assignee: Eiger Biopharmaceuticals, Inc.
    Inventors: David A. Cory, Ingrid Choong, Jeffrey S. Glenn
  • Patent number: 11793760
    Abstract: The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit consisting of: 0.1-25 wt. % of estetrol particles containing at least 80 wt. % of an estetrol component selected from estetrol, estetrol esters and combinations thereof; and 75-99.9 wt. % of one or more pharmaceutically acceptable ingredients; the solid dosage unit comprising at least 100 ?g of the estetrol component; and wherein the solid dosage unit can be obtained by a process comprising wet granulation of estetrol particles having a volume weighted average particle size of 2 ?m to 50 ?m. The solid dosage unit is easy to manufacture and perfectly suited for sublingual, buccal or sublabial administration.
    Type: Grant
    Filed: May 12, 2023
    Date of Patent: October 24, 2023
    Assignee: ESTETRA SRL
    Inventors: Séverine Francine Isabelle Jaspart, Johannes Jan Platteeuw, Denny Johan Marijn Van Den Heuvel
  • Patent number: 11786570
    Abstract: The present invention discloses a composition comprising sugar alcohols or a combination of sugar alcohols and a Tetraselmis extract or either of the former together with niacinamide for treating or preventing dysfunctions of the human hair or skin or as a skin or hair care product.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: October 17, 2023
    Assignee: SYMRISE AG
    Inventors: Martina Herrmann, Sandra Gaebler, Dominik Stuhlmann, Ann-Christin Weseloh
  • Patent number: 11786451
    Abstract: Methods and compositions for improving the appearance of skin are provided. The methods and compositions are especially suited for inhibiting activation of PAR2 in skin by utilizing a synergistic combination of a water lily extract and vitamin B3 compound. The method involves treating hyperpigmented skin by applying a skin care composition containing an effective amount of a combination of water lily extract and vitamin B3 compound to a target portion of skin over the course of a treatment period.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: October 17, 2023
    Assignee: The Procter & Gamble Company
    Inventors: Tomohiro Hakozaki, Bin Fang Deyer, Leo Timothy Laughlin, II
  • Patent number: 11779527
    Abstract: The invention relates to the cosmetic use of an association of (i) at least one polyphenol selected from the monomers and oligomers of flavonoids extracted from vines, the derivatives thereof and the mixtures thereof, and (ii) at least two essential oils selected from peppermint, geranium, lemon balm, lemongrass, rosemary and lavender, for treating and/or preventing oily skin or skin with oily tendencies and/or aesthetic skin problems associated therewith. The invention also relates to a cosmetic method for treating oily skin, and to compositions containing the association. It also relates to the association of polyphenols and the mixture of essential oils for treating acne or skin with oily tendencies.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: October 10, 2023
    Assignee: TOMCAT INTERNATIONAL LIMITED
    Inventors: Mathilde Thomas, Bertrand Thomas
  • Patent number: 11771204
    Abstract: Provided are a method for manufacturing a mask pack for heavy metal adsorption comprising immersing a cellulose nonwoven fabric in an alkali solution by a cold pad batch method and then aging the cellulose nonwoven fabric at room temperature for 10 minutes to 50 minutes, and immersing the cellulose nonwoven fabric in a carboxymethylation solution by the cold pad batch method and then aging the cellulose nonwoven fabric at room temperature to 60° C. for 10 minutes to 3 hours, and a mask pack for heavy metal adsorption manufactured by the method.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: October 3, 2023
    Assignees: LG CHEM, LTD., LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Minsung Park, Haesung Yun, Juhan Kim, Wonjae Lee, Kwang Seoung Jeon, Seul Gi Kang, Seung Min Oh, Ji Ung Park
  • Patent number: 11771636
    Abstract: The present invention relates to a composition comprising adiponectin-derived peptide fragments and, more specifically, to a cosmetic composition and pharmaceutical composition for promoting hair growth comprising, as an active ingredient, one or more adiponectin-derived peptides selected from the group consisting of amino acid sequences of SEQ ID NOS: 1 to 21. The adiponectin-derived peptides activate the cell division of dermal papilla cells and outer root sheath cells of hair follicles, promote hair growth in the hair follicles, and also increase the expression of hair growth factors in the dermal papilla cells, and thus a composition of the present invention comprising the adiponectin-derived peptides can be effectively used to promote hair growth and inhibit hair loss.
    Type: Grant
    Filed: September 3, 2018
    Date of Patent: October 3, 2023
    Assignee: JUNGJINHO EFFECT INC.
    Inventors: Jin Ho Chung, Oh Sang Kwon, Eun Ju Kim, Jin Yong Kim, Dong Hun Lee
  • Patent number: 11766392
    Abstract: Compositions and methods are disclosed herein for inducing (up-regulating) the expression of sulfotransferases in the hair follicles, e.g., the scalp. Increasing sulfotransferase is beneficial for metabolizing pro-drugs that require sulfonation to be activated, e.g., minoxidil sulfate is the active metabolite of minoxidil. A method for combining the compositions described herein with topical minoxidil to enhance minoxidil treatment for androgenetic alopecia is described. Additional methods and compositions include the use of retinoid X receptor agonists, retinoic acid receptor agonists, and nuclear receptor agonists in an RXR?NR heterodimer. Additional methods and compositions include the use of a topical solution containing an alkalinizing agent or an alkalinizing agent used with a penetration enhancer for up-regulating the sulfonating capacity of hair bearing skin, hair follicles, and/or keratinocyte cells.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: September 26, 2023
    Assignee: JUPITER WELLNESS, INC.
    Inventors: Ofer A. Goren, John McCoy